BAYN.DE BA

BAYN.DE Bayer Aktiengesellschaft

Healthcare · Drug Manufacturers - General

1 · Weak Momentum 10.0 · Strong At risk

56.52

-0.07%

About the company

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. It has a commercial agreement with Neste to Jointly scale newgold winter canola for biofuels production. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

0.19% forward
—
0.19% 0.11 EUR
0.11
55.5B
—
-1.46
43.95

52-week range

56.5
low 26.6 high 57.8
Yield Growth Momentum Safety Value Health

Price history

66.6 42.9 19.3 2021 2022 2023 2024 2025 2026 2020-10 · 48.3 2020-11 · 48.2 2020-12 · 49.9 2021-01 · 50.1 2021-02 · 54.0 2021-03 · 53.8 2021-04 · 51.5 2021-05 · 51.2 2021-06 · 50.3 2021-07 · 47.1 2021-08 · 47.0 2021-09 · 48.7 2021-10 · 44.5 2021-11 · 47.0 2021-12 · 53.8 2022-01 · 51.5 2022-02 · 62.1 2022-03 · 62.9 2022-04 · 66.6 2022-05 · 56.7 2022-06 · 57.0 2022-07 · 52.6 2022-08 · 47.4 2022-09 · 53.2 2022-10 · 55.4 2022-11 · 48.3 2022-12 · 57.0 2023-01 · 56.3 2023-02 · 58.7 2023-03 · 59.8 2023-04 · 52.1 2023-05 · 50.7 2023-06 · 53.1 2023-07 · 50.5 2023-08 · 45.5 2023-09 · 40.7 2023-10 · 31.4 2023-11 · 33.6 2023-12 · 28.9 2024-01 · 28.1 2024-02 · 28.4 2024-03 · 27.4 2024-04 · 28.2 2024-05 · 26.4 2024-06 · 27.5 2024-07 · 27.9 2024-08 · 30.3 2024-09 · 24.8 2024-10 · 19.4 2024-11 · 19.3 2024-12 · 21.6 2025-01 · 22.7 2025-02 · 22.1 2025-03 · 23.0 2025-04 · 24.7 2025-05 · 25.5 2025-06 · 27.4 2025-07 · 28.1 2025-08 · 28.2 2025-09 · 26.9 2025-10 · 30.5 2025-11 · 37.0 2025-12 · 44.6 2026-01 · 42.0 2026-02 · 39.4 2026-03 · 38.0 2026-04 · 36.5 2026-05 · 48.4 2026-06 · 48.0 2026-07 · 49.0 2026-08 · 48.0 2026-09 · 46.0 2026-10 · 46.9
Price

Dividend profile

Frequency
Annual
Growth (TTM)
+0.0%
CAGR 3y
-62.0%
-47.7%
0 years

(5-year)

Now 0.2%
0.4% avg 2.7% 5.1%

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

The cash usually arrives later, sometimes a month or more after.

Dividend history

CAGR 3y -62.0% CAGR 5y -47.7%
14 15 16 17 18 19 20 21 22 23 24 25

Per-share dividend by year

Quantic · Free

Unlock valuation & strategy

Two DDM fair values, margin of safety, sector value rank, Dividend Yield Theory, doubling time and max drawdown.

Debt & leverage

129.4%
1.04
0.67
Debt vs cash
Debt Cash
Total debt
38.4B EUR
Total cash
5.1B EUR
10.1B EUR

Latest reported balance-sheet figures.

Held by 1 investor · watched by 1

Appears in these lists

BAYN.DE qualifies for these curated dividend rankings.

Information, not financial advice.

Quantic · Free

Track BAYN.DE and your whole portfolio

Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.

€0

Need more? Pro adds portfolios, options income tracking & more AI. See Pro →